Liver failure after partial hepatic resection: Definition, pathophysiology, risk factors and treatment

Liver International

Volumn 28, Issue 6, 2008, Pages 767-780

  Van Den Broek, Maartje A J ^a   Olde Damink, Steven W M ^a,b   Dejong, Cornelis H C ^a   Lang, Hauke ^c,d   Malagó, Massimo ^b,c   Jalan, Rajiv ^e   Saner, Fuat H ^c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Goal directed treatment; Hepatectomy; Hepatic dysfunction; Post resectional liver failure; Risk analysis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; CHEMOKINE; COMPLEMENT; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOCYANINE GREEN; INTERLEUKIN 6; IRINOTECAN; OXALIPLATIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTIFICIAL EMBOLISM; BLEEDING; BLOOD TRANSFUSION; CLINICAL TRIAL; COMORBIDITY; DIABETES MELLITUS; FATTY LIVER; HEPATIC ENCEPHALOPATHY; HUMAN; HYPOALBUMINEMIA; INCIDENCE; ISCHEMIA; ISCHEMIC PRECONDITIONING; KIDNEY DYSFUNCTION; LIVER CARCINOMA; LIVER CONGESTION; LIVER DISEASE; LIVER FAILURE; LIVER FUNCTION; LIVER RESECTION; LIVER TOXICITY; LIVER TRANSPLANTATION; LIVER WEIGHT; LUNG EDEMA; NONHUMAN; NUTRITIONAL STATUS; OPERATION DURATION; PHAGOCYTOSIS; PLASMAPHERESIS; POSTOPERATIVE INFECTION; REPERFUSION INJURY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENESCENCE; SEX DIFFERENCE; TECHNICAL AID;

DATABASES, BIBLIOGRAPHIC; FEMALE; HEPATECTOMY; HUMANS; LIVER FAILURE; MALE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 44949173027     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01777.x     Document Type: Review

References (145)

1. Broelsch CE, Malago M, Testa G, Valentin Gamazo C. Living donor liver transplantation in adults: Outcome in Europe. Liver Transpl 2000; 6: S64-65.
2. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: Analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002; 236: 397-406; discussion 397-406.
3. Schroeder RA, Marroquin CE, Bute BP, Khuri S, Henderson WG, Kuo PC. Predictive indices of morbidity and mortality after liver resection. Ann Surg 2006; 243: 373-379.
4. Balzan S, Belghiti J, Farges O, et al. The "50-50 criteria"on postoperative day 5: An accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005; 242: 824-8.
5. Imamura H, Seyama Y, Kokudo N, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003; 138: 1198-1206; discussion 1206.
6. Schindl MJ, Redhead DN, Fearon KC, Garden OJ, Wigmore SJ. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 2005; 54: 289-96.
7. Mullen JT, Ribero D, Reddy SK, et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 2007; 204: 854-62.
8. Sugimoto H, Okochi O, Hirota M, et al. Early detection of liver failure after hepatectomy by indocyanine green elimination rate measured by pulse dye-densitometry. J Hepatobiliary Pancreat Surg 2006; 13: 543-8.
9. Nijveldt RJ, Teerlink T, Siroen MP, et al. Elevation of asymmetric dimethylarginine (ADMA) in patients developing hepatic failure after major hepatectomy. J Parenter Enteral Nutr 2004; 28: 382-7.
10. Virani S, Michaelson JS, Hutter MM, et al. Morbidity and mortality after liver resection: Results of the patient safety in surgery study. J Am Coll Surg 2007; 204: 1284-92.
11. McCall J, Koea J, Gunn K, Rodgers M, Jarvis J. Liver resections in Auckland 1998-2001: Mortality, morbidity and blood product use. NZ Med J 2001; 114: 516-9.
12. Benzoni E, Lorenzin D, Baccarani U, et al. Resective surgery for liver tumor: A multivariate analysis of causes and risk factors linked to postoperative complications. Hepatobiliary Pancreat Dis Int 2006; 5: 526-33.
13. Poon RT, Fan ST, Lo CM, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: Analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004; 240: 698-708; discussion 610-708.
14. Dimick JB, Wainess RM, Cowan JA, Upchurch GR Jr, Knol JA, Colletti LM. National trends in the use and outcomes of hepatic resection. J Am Coll Surg 2004; 199: 31-8.
15. Coelho JC, Claus CM, Machuca TN, Sobottka WH, Goncalves CG. Liver resection: 10-year experience from a single institution. Arq Gastroenterol 2004; 41: 229-33.
16. Alfieri S, Carriero C, Caprino P, et al. Avoiding early postoperative complications in liver surgery. A multivariate analysis of 254 patients consecutively observed. Dig Liver Dis 2001; 33: 341-6.
17. Akashi K, Mizuno S, Isaji S. Comparative study of perioperative management of hepatic resection. Dig Dis Sci 2000; 45: 1988-95.
18. Belghiti J, Hiramatsu K, Benoist S, et al. Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection. J Am Coll Surg 2000; 191: 38-46.
19. Das BC, Isaji S, Kawarada Y. Analysis of 100 consecutive hepatectomies: risk factors in patients with liver cirrhosis or obstructive jaundice. World J Surg 2001; 25: 266-72; discussion 263-72.
20. Brancatisano R, Isla A, Habib N. Is radical hepatic surgery safe? Am J Surg 1998; 175: 161-3.
21. Finch MD, Crosbie JL, Currie E, Garden OJ. An 8 year experience of hepatic resection: Indications and outcome. Br J Surg 1998; 85: 315-9.
22. Taniguchi H, Takahashi T. Analysis of 210 elective hepatic resections. Hepatogastroenterology 1997; 44: 1624-31.
23. Rees M, Plant G, Wells J, Bygrave S. One hundred and fifty hepatic resections: Evolution of technique towards bloodless surgery. Br J Surg 1996; 83: 1526-9.
24. Sun HC, Qin LX, Wang L, et al. Risk factors for postoperative complications after liver resection. Hepatobiliary Pancreat Dis Int 2005; 4: 370-4.
25. Buell JF, Rosen S, Yoshida A, et al. Hepatic resection: Effective treatment for primary and secondary tumors. Surgery 2000; 128: 686-93.
26. Midorikawa Y, Kubota K, Takayama T, et al. A comparative study of postoperative complications after hepatectomy in patients with and without chronic liver disease. Surgery 1999; 126: 484-91.
27. Shirabe K, Shimada M, Gion T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 1999; 188: 304-9.
28. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998; 2: 292-8.
29. Detroz B, Sugarbaker PH, Knol JA, Petrelli N, Hughes KS. Causes of death in patients undergoing liver surgery. Cancer Treat Res 1994; 69: 241-57.
30. Bolder U, Brune A, Schmidt S, Tacke J, Jauch KW, Lohlein D. Preoperative assessment of mortality risk in hepatic resection by clinical variables: a multivariate analysis. Liver Transpl Surg 1999; 5: 227-37.
31. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies. Br J Cancer 2006; 94: 982-99.
32. Nadalin S, Testa G, Malago M, et al. Volumetric and functional recovery of the liver after right hepatectomy for living donation. Liver Transpl 2004; 10: 1024-9.
33. Suc B, Panis Y, Belghiti J, Fekete F. 'Natural history'of hepatectomy. Br J Surg 1992; 79: 39-42.
34. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276: 60-6.
35. Morita T, Togo S, Kubota T, et al. Mechanism of postoperative liver failure after excessive hepatectomy investigated using a cDNA microarray. J Hepatobiliary Pancreat Surg 2002; 9: 352-9.
36. Jin X, Zhang Z, Beer-Stolz D, Zimmers TA, Koniaris LG. Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection. Hepatology 2007; 46: 802-12.
37. Yamanaka N, Okamoto E, Kawamura E, et al. Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology 1993; 18: 79-85.
38. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003; 284: G15-26.
39. Kin Y, Nimura Y, Hayakawa N, et al. Doppler analysis of hepatic blood flow predicts liver dysfunction after major hepatectomy. World J Surg 1994; 18: 143-9.
40. Schindl MJ, Millar AM, Redhead DN, et al. The adaptive response of the reticuloendothelial system to major liver resection in humans. Ann Surg 2006; 243: 507-14.
41. Palmes D, Budny TB, Dietl KH, Herbst H, Stratmann U, Spiegel HU. Detrimental effect of sinusoidal overperfusion after liver resection and partial liver transplantation. Transpl Int 2005; 17: 862-71.
42. Hemming AW, Reed AI, Langham MR, Fujita S, van der Werf WJ, Howard RJ. Hepatic vein reconstruction for resection of hepatic tumors. Ann Surg 2002; 235: 850-8.
43. van Leeuwen PA, Hong RW, Rounds JD, Rodrick ML, Wilmore D. Hepatic failure and coma after liver resection is reversed by manipulation of gut contents: The role of endotoxin. Surgery 1991; 110: 169-74; discussion 165-74.
44. Shoup M, Gonen M, D'Angelica M, et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 2003; 7: 325-30.
45. Poon RT, Fan ST. Hepatectomy for hepatocellular carcinoma: Patient selection and postoperative outcome. Liver Transpl 2004; 10: S39-45.
46. Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006; 243: 1-7.
47. Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease: A reappraisal. Ann Surg 1999; 229: 210-5.
48. Little SA, Jarnagin WR, DeMatteo RP, Blumgart LH, Fong Y. Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J Gastrointest Surg 2002; 6: 88-94.
49. Yigitler C, Farges O, Kianmanesh R, Regimbeau JM, Abdalla EK, Belghiti J. The small remnant liver after major liver resection: How common and how relevant? Liver Transpl 2003; 9: S18-25.
50. Fan ST. Methods and related drawbacks in the estimation of surgical risks in cirrhotic patients undergoing hepatectomy. Hepatogastroenterology 2002; 49: 17-20.
51. Kooby DA, Stockman J, Ben-Porat L, et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003; 237: 860-9; discussion 869-70.
52. Luyer MD, Buurman WA, Hadfoune M, et al. Pretreatment with high-fat enteral nutrition reduces endotoxin and tumor necrosis factor-alpha and preserves gut barrier function early after hemorrhagic shock. Shock 2004; 21: 65-71.
53. Silva MA, Muralidharan V, Mirza DF. The management of coagulopathy and blood loss in liver surgery. Semin Hematol 2004; 41: 132-9.
54. Jensen LS, Andersen AJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992; 79: 513-6.
55. Yokoyama Y, Schwacha MG, Samy TS, Bland KI, Chaudry IH. Gender dimorphism in immune responses following trauma and hemorrhage. Immunol Res 2002; 26: 63-76.
56. Koperna T, Kisser M, Schulz F. Hepatic resection in the elderly. World J Surg 1998; 22: 406-12.
57. Suttner SW, Surder C, Lang K, Piper SN, Kumle B, Boldt J. Does age affect liver function and the hepatic acute phase response after major abdominal surgery? Intensive Care Med 2001; 27: 1762-9.
58. Iakova P, Awad SS, Timchenko NA. Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest. Cell 2003; 113: 495-506.
59. Lautz HU, Selberg O, Korber J, Burger M, Muller MJ. Protein-calorie malnutrition in liver cirrhosis. Clin Investig 1992; 70: 478-86.
60. Read JA, Choy ST, Beale PJ, Clarke SJ. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutr Cancer 2006; 55: 78-85.
61. Bozzetti F. Rationale and indications for preoperative feeding of malnourished surgical cancer patients. Nutrition 2002; 18: 953-9.
62. Windsor JA, Hill GL. Weight loss with physiologic impairment. A basic indicator of surgical risk. Ann Surg 1988; 207: 290-6.
63. Fan ST, Lo CM, Lai EC, Chu KM, Liu CL, Wong J. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med 1994; 331: 1547-52.
64. Kooby DA, Fong Y, Suriawinata A, et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 2003; 7: 1034-44.
65. Seifalian AM, Piasecki C, Agarwal A, Davidson BR. The effect of graded steatosis on flow in the hepatic parenchymal microcirculation. Transplantation 1999; 68: 780-4.
66. Serafin A, Rosello-Catafau J, Prats N, Xaus C, Gelpi E, Peralta C. Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol 2002; 161: 587-601.
67. Selzner M, Clavien PA. Failure of regeneration of the steatotic rat liver: Disruption at two different levels in the regeneration pathway. Hepatology 2000; 31: 35-42.
68. Marcos A, Fisher RA, Ham JM, et al. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000; 69: 1375-9.
69. Cherqui D, Benoist S, Malassagne B, Humeres R, Rodriguez V, Fagniez PL. Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage. Arch Surg 2000; 135: 302-8.
70. Makino H, Shimizu H, Ito H, et al. Changes in growth factor and cytokine expression in biliary obstructed rat liver and their relationship with delayed liver regeneration after partial hepatectomy. World J Gastroenterol 2006; 12: 2053-9.
71. Bruix J, Castells A, Bosch J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure. Gastroenterology 1996; 111: 1018-22.
72. Lau W, Leung K, Leung TW, et al. A logical approach to hepatocellular carcinoma presenting with jaundice. Ann Surg 1997; 225: 281-5.
73. Hemming AW, Scudamore CH, Shackleton CR, Pudek M, Erb SR. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg 1992; 163: 515-8.
74. Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006; 24: 2065-72.
75. Nakano H, Oussoultzoglou E, Rosso E, et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 2008; 247: 118-24.
76. DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002; 22: 27-42.
77. Rubbia-Brandt L, Mentha G, Terris B. Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases. J Am Coll Surg 2006; 202: 199-200.
78. Fong Y, Bentrem DJ. CASH (chemotherapy-associated steatohepatitis) costs. Ann Surg 2006; 243: 8-9.
79. Gazzaniga GM, Cappato S, Belli FE, Bagarolo C, Filauro M. Assessment of hepatic reserve for the indication of hepatic resection: How I do it. J Hepatobiliary Pancreat Surg 2005; 12: 27-30.
80. Mullin EJ, Metcalfe MS, Maddern GJ. How much liver resection is too much? Am J Surg 2005; 190: 87-97.
81. Henkel AS, Buchman AL. Nutritional support in patients with chronic liver disease. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 202-9.
82. Katsuramaki T, Mizuguchi T, Kawamoto M, et al. Assessment of nutritional status and prediction of postoperative liver function from serum apolioprotein a-1 levels with hepatectomy. World J Surg 2006; 30: 1886-91.
83. Zimmermann H, Reichen J. Hepatectomy: Preoperative analysis of hepatic function and postoperative liver failure. Dig Surg 1998; 15: 1-11.
84. Lamade W, Glombitza G, Fischer L, et al. The impact of 3-dimensional reconstructions on operation planning in liver surgery. Arch Surg 2000; 135: 1256-61.
85. Lang H, Radtke A, Liu C, Fruhauf NR, Peitgen HO, Broelsch CE. Extended left hepatectomy-modified operation planning based on three-dimensional visualization of liver anatomy. Langenbecks Arch Surg 2004; 389: 306-10.
86. Wigmore SJ, Redhead DN, Yan XJ, et al. Virtual hepatic resection using three-dimensional reconstruction of helical computed tomography angioportograms. Ann Surg 2001; 233: 221-6.
87. Vauthey JN, Abdalla EK, Doherty DA, et al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl 2002; 8: 233-40.
88. Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 1997; 84: 1255-9.
89. Redaelli CA, Dufour JF, Wagner M, et al. Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg 2002; 235: 77-85.
90. Ercolani G, Grazi GL, Calliva R, et al. The lidocaine (MEGX) test as an index of hepatic function: Its clinical usefulness in liver surgery. Surgery 2000; 127: 464-71.
91. Hepner GW, Vesell ES. Quantitative assessment of hepatic function by breath analysis after oral administration of (14C) aminopyrine. Ann Intern Med 1975; 83: 632-8.
92. Gill RA, Goodman MW, Golfus GR, Onstad GR, Bubrick MP. Aminopyrine breath test predicts surgical risk for patients with liver disease. Ann Surg 1983; 198: 701-4.
93. Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg 1964; 1: 1-85.
94. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-71.
95. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 1999; 19: 329-38.
96. Cucchetti A, Ercolani G, Vivarelli M, et al. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 2006; 12: 966-71.
97. Madoff DC, Abdalla EK, Vauthey JN. Portal vein embolization in preparation for major hepatic resection: Evolution of a new standard of care. J Vasc Interv Radiol 2005; 16: 779-90.
98. Azoulay D, Castaing D, Smail A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 2000; 231: 480-6.
99. Imamura H, Shimada R, Kubota M, et al. Preoperative portal vein embolization: An audit of 84 patients. Hepatology 1999; 29: 1099-105.
100. Kokudo N, Tada K, Seki M, et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 2001; 34: 267-72.
101. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg 2000; 232: 777-85.
102. Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 2004; 240: 1037-49; discussion 1049-51.
103. Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007; 356: 1545-59.
104. Tanaka K, Shimada H, Matsuo K, Ueda M, Endo I, Togo S. Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases. Eur J Surg Oncol 2007; 33: 329-35.
105. Melendez JA, Arslan V, Fischer ME, et al. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg 1998; 187: 620-5.
106. Jones RM, Moulton CE, Hardy KJ. Central venous pressure and its effect on blood loss during liver resection. Br J Surg 1998; 85: 1058-60.
107. Dixon E, Vollmer CM Jr, Bathe OF, Sutherland F. Vascular occlusion to decrease blood loss during hepatic resection. Am J Surg 2005; 190: 75-86.
108. Belghiti J, Noun R, Zante E, Ballet T, Sauvanet A. Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study. Ann Surg 1996; 224: 155-61.
109. Kanoria S, Jalan R, Davies NA, Seifalian AM, Williams R, Davidson BR. Remote ischaemic preconditioning of the hind limb reduces experimental liver warm ischaemia-reperfusion injury. Br J Surg 2006; 93: 762-8.
110. Koti RS, Yang W, Dashwood MR, Davidson BR, Seifalian AM. Effect of ischemic preconditioning on hepatic microcirculation and function in a rat model of ischemia reperfusion injury. Liver Transpl 2002; 8: 1182-91.
111. Fernandez L, Carrasco-Chaumel E, Serafin A, et al. Is ischemic preconditioning a useful strategy in steatotic liver transplantation? Am J Transplant 2004; 4: 888-99.
112. Clavien PA, Selzner M, Rudiger HA, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003; 238: 843; discussion 842-51.
113. Petrowsky H, McCormack L, Trujillo M, Selzner M, Jochum W, Clavien PA. A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann Surg 2006; 244: 921-8; discussion 928-30.
114. Richter B, Schmandra TC, Golling M, Bechstein WO. Nutritional support after open liver resection: A systematic review. Dig Surg 2006; 23: 139-45.
115. Hwang S, Lee SG, Jang SJ, et al. The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation. Liver Transpl 2004; 10: 721-5.
116. Nakamuta M, Morizono S, Soejima Y, et al. Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation. Transplantation 2005; 80: 608-12.
117. Pitt HA, Gomes AS, Lois JF, Mann LL, Deutsch LS, Longmire WP Jr. Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann Surg 1985; 201: 545-53.
118. Hatfield AR, Tobias R, Terblanche J, et al. Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet 1982; 2: 896-9.
119. Sewnath ME, Karsten TM, Prins MH, Rauws EJ, Obertop H, Gouma DJ. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg 2002; 236: 17-27.
120. Kanai M, Nimura Y, Kamiya J, et al. Preoperative intrahepatic segmental cholangitis in patients with advanced carcinoma involving the hepatic hilus. Surgery 1996; 119: 498-504.
121. Kimura F, Shimizu H, Yoshidome H, et al. Circulating cytokines, chemokines, and stress hormones are increased in patients with organ dysfunction following liver resection. J Surg Res 2006; 133: 102-12.
122. Sen S, Mohseni S, Cheshire LM, Williams R, Bjornsson E, Jalan R. Baseline SOFA score and its lack of early improvement accurately predicts mortality in patients with acute-on-chronic liver failure. Hepatology 2004; 40: 498A.
123. Sass DA, Shakil AO. Fulminant hepatic failure. Liver Transpl 2005; 11: 594-605.
124. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-77.
125. Matsumata T, Taketomi A, Fujiwara Y, Shimada M, Takenaka K, Sugimachi K. Renal function after elective hepatic resection. Hepatogastroenterology 1996; 43: 602-7.
126. Olde Damink SW, Jalan R, Deutz NE, et al. The kidney plays a major role in the hyperammonemia seen after simulated or actual GI bleeding in patients with cirrhosis. Hepatology 2003; 37: 1277-85.
127. Thasler WE, Bein T, Jauch KW. Perioperative effects of hepatic resection surgery on hemodynamics, pulmonary fluid balance, and indocyanine green clearance. Langenbecks Arch Surg 2002; 387: 271-5.
128. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy -definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-21.
129. Shawcross D, Jalan R. The pathophysiologic basis of hepatic encephalopathy: Central role for ammonia and inflammation. Cell Mol Life Sci 2005; 62: 2295-304.
130. Jalan R, Olde Damink SW, Hayes PC, Deutz NE, Lee A. Pathogenesis of intracranial hypertension in acute liver failure: Inflammation, ammonia and cerebral blood flow. J Hepatol 2004; 41: 613-20.
131. Jalan R. Acute liver failure: Current management and future prospects. J Hepatol 2005; 42(Suppl.): S115-23.
132. Wu CC, Yeh DC, Lin MC, Liu TJ, P'Eng FK. Prospective randomized trial of systemic antibiotics in patients undergoing liver resection. Br J Surg 1998; 85: 489-93.
133. Rolando N, Gimson A, Wade J, Philpott-Howard J, Casewell M, Williams R. Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology 1993; 17: 196-201.
134. Onodera K, Sakata H, Yonekawa M, Kawamura A. Artificial liver support at present and in the future. J Artif Organs 2006; 9: 17-28.
135. Liu J, Kjaergard LL, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for liver failure: A cochrane hepato-biliary group protocol. Liver 2002; 22: 433-8.
136. Sen S, Williams R, Jalan R. Emerging indications for albumin dialysis. Am J Gastroenterol 2005; 100: 468-75.
137. Krisper P, Stauber RE. Technology insight: Artificial extracorporeal liver support -how does Prometheus compare with MARS? Nat Clin Pract Nephrol 2007; 3: 267-76.
138. Heemann U, Treichel U, Loock J, et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study. Hepatology 2002; 36: 949-58.
139. Rittler P, Ketscher C, Inthorn D, Jauch KW, Hartl WH. Use of the molecular adsorbent recycling system in the treatment of postoperative hepatic failure and septic multiple organ dysfunction -preliminary results. Liver Int 2004; 24: 136-41.
140. van de Kerkhove MP, de Jong KP, Rijken AM, de Pont AC, van Gulik TM. MARS treatment in posthepatectomy liver failure. Liver Int 2003; 23(Suppl. 3): 44-51.
141. Kellersmann R, Gassel HJ, Buhler C, Thiede A, Timmermann W. Application of Molecular Adsorbent Recirculating System in patients with severe liver failure after hepatic resection or transplantation: Initial single-centre experiences. Liver 2002; 22(Suppl. 2): 56-8.
142. Krisper P, Haditsch B, Stauber R, et al. In vivo quantification of liver dialysis: Comparison of albumin dialysis and fractionated plasma separation. J Hepatol 2005; 43: 451-7.
143. Demetriou AA, Brown RS Jr, Busuttil RW, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004; 239: 660-7; discussion 667-70.
144. Jalan R, Pollok A, Shah SH, Madhavan K, Simpson KJ. Liver derived pro-inflammatory cytokines may be important in producing intracranial hypertension in acute liver failure. J Hepatol 2002; 37: 536-8.
145. Otsuka Y, Duffy JP, Saab S, et al. Postresection hepatic failure: successful treatment with liver transplantation. Liver Transpl 2007; 19: 329-38.